J. Sawyer

4.8k total citations · 1 hit paper
27 papers, 3.8k citations indexed

About

J. Sawyer is a scholar working on Psychiatry and Mental health, Infectious Diseases and Pathology and Forensic Medicine. According to data from OpenAlex, J. Sawyer has authored 27 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 8 papers in Infectious Diseases and 8 papers in Pathology and Forensic Medicine. Recurrent topics in J. Sawyer's work include Migraine and Headache Studies (13 papers), HIV/AIDS drug development and treatment (8 papers) and Trigeminal Neuralgia and Treatments (7 papers). J. Sawyer is often cited by papers focused on Migraine and Headache Studies (13 papers), HIV/AIDS drug development and treatment (8 papers) and Trigeminal Neuralgia and Treatments (7 papers). J. Sawyer collaborates with scholars based in United States, United Kingdom and Argentina. J. Sawyer's co-authors include Richard B. Lipton, Walter F. Stewart, Andrew Dowson, Joshua N. Liberman, RB Lipton, John Edmeads, Ken Kolodner, WF Stewart, Joshua Liberman and Kenneth B. Kolodner and has published in prestigious journals such as JAMA, Neurology and Pain.

In The Last Decade

J. Sawyer

25 papers receiving 3.6k citations

Hit Papers

Development and testing of the Migraine Disability Assess... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Sawyer United States 18 3.1k 1.8k 813 347 273 27 3.8k
Franco Granella Italy 31 2.7k 0.9× 2.0k 1.1× 1.2k 1.5× 185 0.5× 336 1.2× 102 3.6k
José Geraldo Speciali Brazil 33 1.9k 0.6× 1.2k 0.7× 784 1.0× 256 0.7× 518 1.9× 128 3.1k
Federica Galli Italy 31 2.0k 0.6× 599 0.3× 606 0.7× 548 1.6× 151 0.6× 114 2.9k
Ángel L. Guerrero Spain 26 1.6k 0.5× 1.1k 0.6× 555 0.7× 195 0.6× 907 3.3× 255 2.7k
Dewey K. Ziegler United States 30 1.7k 0.5× 852 0.5× 680 0.8× 385 1.1× 493 1.8× 109 3.0k
Manjit Matharu United Kingdom 39 5.0k 1.6× 3.8k 2.1× 2.3k 2.8× 450 1.3× 1.0k 3.8× 224 6.2k
Gretchen E. Tietjen United States 34 2.0k 0.6× 537 0.3× 432 0.5× 200 0.6× 448 1.6× 91 3.2k
Paul G. Ritvo Canada 15 1.1k 0.4× 1.6k 0.9× 184 0.2× 207 0.6× 593 2.2× 17 3.4k
A. David Rothner United States 32 1.9k 0.6× 517 0.3× 576 0.7× 576 1.7× 825 3.0× 125 3.2k
Christopher Christodoulou United States 31 863 0.3× 1.7k 1.0× 173 0.2× 59 0.2× 757 2.8× 50 3.4k

Countries citing papers authored by J. Sawyer

Since Specialization
Citations

This map shows the geographic impact of J. Sawyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Sawyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Sawyer more than expected).

Fields of papers citing papers by J. Sawyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Sawyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Sawyer. The network helps show where J. Sawyer may publish in the future.

Co-authorship network of co-authors of J. Sawyer

This figure shows the co-authorship network connecting the top 25 collaborators of J. Sawyer. A scholar is included among the top collaborators of J. Sawyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Sawyer. J. Sawyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Eastell, Richard, et al.. (2011). Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: The OCEAN study. Journal of Bone and Mineral Research. 26(6). 1303–1312. 93 indexed citations
4.
Holdich, Tom & J. Sawyer. (2008). Influence of food on the pharmacokinetics of apricitabine, a novel deoxycytidine analogue reverse transcriptase inhibitor. Expert Opinion on Pharmacotherapy. 9(12). 2021–2025. 3 indexed citations
5.
Sawyer, J., et al.. (2008). Pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers treated with trimethoprim-sulphamethoxazole. Journal of Clinical Pharmacy and Therapeutics. 33(1). 45–54. 7 indexed citations
6.
Cahn, Pedro, et al.. (2008). Multiple-Dose Pharmacokinetics of Apricitabine, a Novel Nucleoside Reverse Transcriptase Inhibitor, in Patients with HIV-1 Infection. Clinical Drug Investigation. 28(2). 129–138. 3 indexed citations
7.
Holdich, Tom, et al.. (2007). Effect of Lamivudine on the Plasma and Intracellular Pharmacokinetics of Apricitabine, a Novel Nucleoside Reverse Transcriptase Inhibitor, in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 51(8). 2943–2947. 23 indexed citations
8.
Wainberg, Mark A., Pedro Cahn, Richard C. Bethell, J. Sawyer, & Susan Cox. (2007). Apricitabine: A Novel Deoxycytidine Analogue Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Nucleoside-Resistant HIV Infection. Antiviral chemistry & chemotherapy. 18(2). 61–70. 14 indexed citations
9.
Cahn, Pedro, Isabel Cassetti, Robin Wood, et al.. (2006). Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients. AIDS. 20(9). 1261–1268. 33 indexed citations
10.
Holdich, Tom, et al.. (2006). Pharmacokinetics of Single Oral Doses of Apricitabine, a Novel Deoxycytidine Analogue Reverse Transcriptase Inhibitor, in Healthy Volunteers. Clinical Drug Investigation. 26(5). 279–286. 12 indexed citations
11.
Wainberg, Mark A., J. Sawyer, Julio Montaner, et al.. (2005). Challenges for the Clinical Development of New Nucleoside Reverse Transcriptase Inhibitors for HIV Infection. Antiviral Therapy. 10(1). 13–28. 27 indexed citations
13.
Bakheit, A. M. O. & J. Sawyer. (2002). The effects of botulinum toxin treatment on associated reactions of the upper limb on hemiplegic gait–a pilot study. Disability and Rehabilitation. 24(10). 519–522. 34 indexed citations
14.
Holmes, William F., E. Anne MacGregor, J. Sawyer, & Richard B. Lipton. (2001). Information About Migraine Disability Influences Physicians' Perceptions of Illness Severity and Treatment Needs. Headache The Journal of Head and Face Pain. 41(4). 343–350. 241 indexed citations
15.
Williams, Paul, Andrew Dowson, Alan M. Rapoport, & J. Sawyer. (2001). The Cost Effectiveness of Stratified Care in the Management of Migraine. PharmacoEconomics. 19(8). 819–829. 27 indexed citations
16.
Lipton, Richard B., Walter F. Stewart, J. Sawyer, & John Edmeads. (2001). Clinical Utility of an Instrument Assessing Migraine Disability: The Migraine Disability Assessment (MIDAS) Questionnaire. Headache The Journal of Head and Face Pain. 41(9). 854–861. 266 indexed citations
17.
Stewart, Walter F., Richard B. Lipton, Kenneth B. Kolodner, et al.. (2000). Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 88(1). 41–52. 443 indexed citations
18.
Lipton, Richard B., Walter F. Stewart, Andrew Stone, Miguel J. A. Láinez, & J. Sawyer. (2000). Stratified Care vs Step Care Strategies for Migraine. JAMA. 284(20). 2599–2599. 272 indexed citations
19.
Fraser, William D., et al.. (1997). A double-blind, multicentre, placebo-controlled study of tiludronate in Paget's disease of bone. Postgraduate Medical Journal. 73(862). 496–502. 37 indexed citations
20.
Schoenen, Jean & J. Sawyer. (1997). Zolmitriptan (Zomig™, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: An overview of efficacy. Cephalalgia. 17(18_suppl). 28–40. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026